Intervention aims to reduce amyloid aggregation in type 2 diabetes, suggesting a potential therapeutic pathway.
hIAPP, human islet amyloid polypeptide, aggregates have been implicated in the development of type 2 diabetes mellitus (T2DM). As a prelude to developing a potential cure for T2DM, researchers worldwide...
No takes yet. Share an insight, caveat, or question.
Kawa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: